Skip to main content
. 2023 Feb 13;14:1097139. doi: 10.3389/fendo.2023.1097139

Table 3.

Comparison of characteristics of diabetes mellitus after total pancreatectomy and type 1 diabetes in the long-term follow-up period.

Characteristics TP(n = 80) T1DM(n = 80) P value
Age at last follow-up (years), mean ± SD 62.59 ± 10.41 44.01 ± 17.22 < 0.001
Male, n (%) 36 (45) 30 (37.5) 0.422
Diabetes duration (months), median (IQR) 20 (7, 63)* 132 (72, 204) < 0.001
BMI (kg/m2), mean ± SD 20.33 ± 2.39 20.92 ± 1.76 0.079
HbA1c (%), mean ± SD 7.43 ± 0.76 7.66 ± 1.12 0.128
C-peptide (ng/ml), median (IQR) <0.05 <0.05
Hypoglycemic events, n of patients/total n (%) 47/80 (58.8) 57/80 (71.3) 0.097
CGM measurements
 Mean glucose value (mmol/L), mean ± SD 8.61 ± 1.59 8.25 ± 1.62 0.665
 SD (mmol/L), mean ± SD 3.27 ± 0.71 3.24 ± 1.22 0.967
 CV (%), mean ± SD 37.49 ± 8.26 38.22 ± 6.94 0.851
 Maximum glucose value (mmol/L), mean ± SD 18.80 ± 3.51 17.71 ± 2.56 0.491
 Minimum glucose value (mmol/L), mean ± SD 2.93 ± 0.56 3.20 ± 0.69 0.396
 TIR (%) (3.9-10 mmol/L), mean ± SD 71.92 ± 9.43 70.19 ± 14.99 0.787
 TAR (%) (>10 mmol/L), mean ± SD 23.41 ± 9.78 24.38 ± 14.51 0.877
 TBR (%) (<3.9 mmol/L), mean ± SD 4.68 ± 4.54 5.42 ± 3.13 0.707
Insulin regimen
 Daily insulin dose (units/kg/day), mean ± SD 0.49 ± 0.19 0.65 ± 0.19 < 0.001
 Daily insulin dose (units/day), mean ± SD 27.09 ± 11.88 38.74 ± 11.44 < 0.001
 Basal percentage (%), mean ± SD 39.4 ± 16.5 43.9 ± 9.9 0.035
Insulin pump
 Daily insulin dose (units/kg/day), mean ± SD 0.44 ± 0.14 0.66 ± 0.14 < 0.001
 Daily insulin dose (units), mean ± SD 24.81 ± 8.05 39.93 ± 10.22 < 0.001
 Basal percentage (%), mean ± SD 44.1 ± 14.5 49.8 ± 8.86 0.138

TP, total pancreatectomy; T1DM, type 1 diabetes mellitus; BMI, body mass index; HbA1c, glycosylated hemoglobin A1c; CGM, continuous glucose monitoring; SD, standard deviation of glucose; CV, coefficient of variation; TIR, time in range; TAR, time above range; TBR, time below range.

*Diabetes duration since total pancreatectomy.

†The CGM data were available in seven patients undergoing TP and eight with T1DM.

‡Insulin pumps were used in 14 patients after TP and 24 patients with T1DM.

P values < 0.05 were shown in bold.